Dimethylaminoparthenolide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDimethylaminoparthenolide
Drug Alias NameLC-1NSC-734325DMAPT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeuchemix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeuchemix
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A